| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 6,245,119 | 7,407,186 | 5,333,901 | | Cost of Revenue | 4,915,942 | 5,828,027 | 4,122,211 | | | Gross Profit | 1,329,177 | 1,579,159 | 1,211,690 | | | Operating Expenses | | Research Development | 274,499 | 300,429 | 277,467 | | Selling General and Administrative | 527,283 | 511,857 | 392,004 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 527,395 | 766,873 | 542,219 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (34,338) | (117,068) | 30,563 | | Earnings Before Interest And Taxes | 493,057 | 649,805 | 572,782 | | Interest Expense | 14,293 | 24,164 | 17,128 | | Income Before Tax | 478,764 | 625,641 | 555,654 | | Income Tax Expense | 126,886 | 154,546 | 147,904 | | Minority Interest | (38,450) | (60,704) | (68,869) | | | | Net Income From Continuing Ops | 312,939 | 410,780 | 338,263 | | | Non-recurring Events | | Discontinued Operations | (24,300) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 288,639 | 410,780 | 338,263 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $288,639 | $410,780 | $338,263 |
|
0.51% Nasdaq 
Income Statement
